Cancer Biomarkers Market Size to Grow USD 42170 Million by 2030 at a CAGR of 11.4% | Valuates Reports [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
The Global Cancer Biomarkers Market was valued at USD 19580 Million in 2023 and is anticipated to reach USD 42170 Million by 2030, witnessing a CAGR of 11.4% during the forecast period 2024-2030. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-5B8063/Global_Cancer_Biomarker_Market Major Factors Driving the Growth of Cancer Biomarkers Market: Precision medicine and tailored therapeutic advancements have a major role in driving the growth of the cancer biomarker market. With the growing knowledge of the molecular and genetic causes of cancer, biomarkers allow for more accurate diagnosis, prognosis, and therapy choices based on the unique characteristics of each patient. This individualized strategy is becoming more and more popular in clinical practice since it decreases side effects and increases therapeutic success. Additionally, next-generation sequencing and liquid biopsies—two cutting-edge technologies for the identification and validation of new bioma
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Africa Malaria Diagnostics Market Size, Share & Trends Analysis Report 2024-2030: Adaptation of the "Zero Malaria" Agenda to Bolster Growth with Increased Initiatives by Market Players and Private Investors [Yahoo! Finance]Yahoo! Finance
- Proteomics Market to Reach $161.9 billion, Globally, by 2035 at 14.2% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
- Why Is Bio-Rad (BIO) Up 7.8% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- China Biopsy Market Report 2024-2032: Chinese Government Releases 8 Year Plan for Cancer Prevention and Treatment, to Achieve 46.6% Five Year Survival Rate among Cancer Patients by 2030 [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Laboratories, Inc. (NYSE: BIO) had its "hold" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $315.00 price target on the stock, down previously from $440.00.MarketBeat
BIO
Earnings
- 5/7/24 - Beat
BIO
Sec Filings
- 6/14/24 - Form 4
- 6/13/24 - Form 144
- 5/9/24 - Form SD
- BIO's page on the SEC website